- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03080337
Group vs. Traditional Diabetes Prenatal Care
December 17, 2019 updated by: University of Wisconsin, Madison
Group Prenatal Care Compared to Traditional Prenatal Care for Women With Pre-gestational Diabetes: A Randomized Clinical Trial.
This study aims to use an innovative and integrated educational curriculum to deliver prenatal care and diabetes care for pre-gestational diabetic women from approximately the first trimester of pregnancy through delivery and the early postpartum period in a group care model.
The group care model will be compared to a control group, a traditional, individual care model.
Study Overview
Study Type
Interventional
Enrollment (Actual)
12
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Wisconsin
-
Madison, Wisconsin, United States, 53715
- UnityPoint Health- Meriter Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Clinically confirmed viable pregnancy at the time of enrollment.
- Able to provide consent for participation.
- Diabetes diagnosed prior to 12 weeks gestation.
- Initiation of care by 20 weeks gestation.
- Age 18 years or older.
Exclusion Criteria:
- Not planning to deliver at UnityPoint Health- Meriter Hospital.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Traditional Care
If the participant is randomized to the individual prenatal care model, she will continue to receive individualized care in the prenatal clinic.
This includes being seen by both a MFM specialist and possibly an endocrinologist at each prenatal visit.
During the prenatal visit, the individual caregivers are responsible for discussing educational topics that they feel are relevant to the patient.
Patients are seen every two weeks for Traditional Care.
|
|
Experimental: Group Care
If the participant is randomized into the group prenatal care model she will be placed in a group of approximately 6-10 women of approximately the same gestational age.
These women will then have sessions scheduled at the same intervals they would have had their traditional prenatal visits, every two weeks until 36 weeks and then weekly until delivery, 12 sessions in total.
Each session will last between 90-120 minutes.
In the group prenatal care model, the entire visit time will be face to face with a provider and the group.
Billing will be done through the standard reimbursement system since the program will follow the schedule of prenatal visits recommended by the American Congress of Obstetricians and Gynecologist.
|
Participation in 12 group sessions with 6-10 women who are also pregnant and have diabetes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Compliance with glucose testing over time
Time Frame: 2 years
|
Compare the glucose compliance of participants in the group care model to the control group: a traditional, individual care model.
|
2 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Maternal Weight Gain (kilograms)
Time Frame: 2 years
|
Compare maternal weight gain of participants in the group care model to the control group: a traditional, individual care model.
|
2 years
|
Length of stay for delivery (days)
Time Frame: 2 years
|
Compare maternal hospital length of stay for delivery of participants in the group care model to the control group: a traditional, individual care model.
|
2 years
|
Presence of infection (Y/N)
Time Frame: 2 years
|
Compare presence of infection in participants in the group care model to the control group: a traditional, individual care model.
|
2 years
|
Type of Delivery (Vaginal, C-Section, Vacuum, Forceps, other)
Time Frame: 2 years
|
Compare type of delivery in participants in the group care model to the control group: a traditional, individual care model.
|
2 years
|
Blood Pressure (mm Hg)
Time Frame: 2 years
|
Compare blood pressures in participants in the group care model to the control group: a traditional, individual care model.
|
2 years
|
Neonatal Birth Weight (grams)
Time Frame: 2 years
|
Compare neonatal birth weight of participants in the group care model to the control group: a traditional, individual care model.
|
2 years
|
Neonatal Length of stay (days)
Time Frame: 2 years
|
Compare neonatal length of stay of participants in the group care model to the control group: a traditional, individual care model.
|
2 years
|
Neonatal APGAR Score (0-10)
Time Frame: 2 years
|
Compare neonatal APGAR score of participants in the group care model to the control group: a traditional, individual care model.
|
2 years
|
Gestational Age at Delivery (weeks)
Time Frame: 2 years
|
Compare gestational age at delivery of participants in the group care model to the control group: a traditional, individual care model.
|
2 years
|
Pregnancy related and Diabetes related knowledge acquired during pregnancy (survey)
Time Frame: 2 years
|
Compare pregnancy and diabetes related knowledge of participants in the group care model to the control group: a traditional, individual care model.
|
2 years
|
Patient and care giver satisfaction (survey)
Time Frame: 2 years
|
Compare satisfaction of participants and their respective providers in the group care model to the control group: a traditional, individual care model.
|
2 years
|
Cost-effectiveness (dollars per hour)
Time Frame: 2 years
|
Compare cost-effectiveness of the group care model to the control group: a traditional, individual care model.
|
2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 17, 2017
Primary Completion (Actual)
February 22, 2018
Study Completion (Actual)
February 22, 2018
Study Registration Dates
First Submitted
February 27, 2017
First Submitted That Met QC Criteria
March 9, 2017
First Posted (Actual)
March 15, 2017
Study Record Updates
Last Update Posted (Actual)
December 19, 2019
Last Update Submitted That Met QC Criteria
December 17, 2019
Last Verified
December 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2016-015
- A532860 (Other Identifier: UW Madison)
- SMPH/OBSTET & GYNECOL/OBSTET (Other Identifier: UW Madison)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Data will be shared in a REDCap database with University Hospitals, Cleveland.
IPD Sharing Time Frame
At time of study completion for up to 1 year.
IPD Sharing Access Criteria
De-identified data variables will be shared as this will be a shared enrollment effort.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
Guang NingRecruitingType 2 Diabetes Mellitus | Type1 Diabetes Mellitus | Monogenetic Diabetes | Pancreatogenic Diabetes | Drug-Induced Diabetes Mellitus | Other Forms of Diabetes MellitusChina
-
University of Trás-os-Montes and Alto DouroCompletedType 2 Diabetes Mellitus | Diabetes-Related ComplicationsPortugal
-
Northern Care Alliance NHS Foundation TrustBrighter ABCompletedDiabetes type1 | Diabetes type2United Kingdom
-
VeraLight, Inc.InLight SolutionsUnknownGestational Diabetes | Insulin Dependent Diabetes | Non Insulin Dependent DiabetesUnited States
-
Garvan Institute of Medical ResearchWeizmann Institute of ScienceActive, not recruitingType 2 Diabetes Mellitus | Pre DiabetesAustralia
-
Oregon State UniversitySanofiCompletedType I or Type II Diabetes (Excludes Gestational Diabetes)
-
Taichung Veterans General HospitalNational Health Research Institutes, TaiwanRecruitingDiabetes Complications | Type 2 Diabetes | Maturity-Onset Diabetes of the Young (MODY)Taiwan
-
Peking Union Medical College HospitalUnknownType 2 Diabetes Mellitus | Type 1 Diabetes Mellitus | Gestational Diabetes Mellitus | Pancreatogenic Diabetes Mellitus | Pregestational Diabetes Mellitus | Diabetes Patients in Perioperative PeriodChina
-
University of RoehamptonRecruitingType2 Diabetes Mellitus | Pre DiabetesUnited Kingdom
Clinical Trials on Group Care
-
Johns Hopkins UniversityJohns Hopkins Alliance for a Healthier WorldActive, not recruiting
-
Indiana UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Instituto de Investigacion Sanitaria La FeCompleted
-
University College CorkUnknownPelvic Girdle Pain | Symphysio Pubic DysfunctionIreland
-
Federal University of PelotasActive, not recruitingFibromyalgia | Fibromyalgia, PrimaryBrazil
-
Oslo University HospitalUniversity Hospital of North NorwayActive, not recruiting
-
Atatürk UniversityActive, not recruitingNursing Care for Gastrointestinal Cancer PatientsTurkey
-
DeNova ResearchCompletedFacial Rejuvenation With Neurotoxins and/or Hyaluronic Acid FillersUnited States
-
Yale UniversityUnited Health FoundationCompletedSexually Transmitted Diseases | Premature Birth | Pregnancy | Infant, Low Birth Weight | Postpartum PeriodUnited States
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...Completed